← Back to catalogue

ManaMed

FDA UDI

Class I (US FDA UDI)

by Manamed Llc

Identity

Trade Name
ManaMed FDA UDI
Generic Name
Transdermal medication patch FDA UDI
Device Name
ManaMed Lidocaine patches have 4% lidocaine providing odorless pain-relieving ointment on a breathable adhesive patch. Same active ingredients as common national brands. No irritation, no burning, targets aggravated nerves, fast acting. FDA UDI
Model / Reference
Lidocaine 4% pain releiving gel patch / 5 patches FDA UDI
Description
ManaMed Lidocaine patches have 4% lidocaine providing odorless pain-relieving ointment on a breathable adhesive patch. Same active ingredients as common national brands. No irritation, no burning, targets aggravated nerves, fast acting. FDA UDI

Identifiers

Catalog Number
LIDOOTC5 FDA UDI
Primary DI / UDI-DI
00810113682464 FDA UDI
FDA Product Code
OMW FDA UDI
GMDN Term
Transdermal medication patch FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
890.5710 FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

ManaMed by Manamed Llc — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Manamed Llc

Sources (1)

  • FDA UDI d678e24a-c52c-4d7a-8537-7a64a6d35c80 36 fields · synced Jun 1, 2026